DEPDC1 protein, human: Clinical Trials

3 trials of DEPDC1 protein, human, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Unknown 1

Follow DEPDC1 protein, human: new trials by email Literature Review of DEPDC1 protein, human trials Research Report on DEPDC1 protein, human

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer
MPHOSPH1 and DEPDC1 - Bladder Cancer
Phase 2UnknownIwate Medical University1502008-02-012011-06-23
Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors
5 peptide vaccines of KOC1, TTK, CO16, DEPDC1, MPHOSPH1 - Metastatic Tumors
Phase 1CompletedKyushu University182007-11-012011-06-23
Novel Peptide Vaccination for Patients With Advanced Bladder Cancer
MPHOSPH1 and DEPDC1 - Bladder Cancer
Phase 1CompletedIwate Medical University202007-02-012010-10-21

Conditions studied

Urinary Bladder Neoplasms (2)  ·  Neoplasm Metastasis (1)

Sponsors

Iwate Medical University (2)  ·  Kyushu University (1)

Countries

Japan (3)

Top investigators

Tomoaki Fujioka, M.D. & Ph.D. (2)  ·  Kenzaburo Tani, MD,phD (1)

Results publications

PMID 17409436, PMID 17452976